| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ Months |
| 被験者数 | 64 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64 |
| 体型 | 肥満, 平均 |
この研究の注釈：
Six months supplementation of 1,000mcg chromium to diabetic persons with varying HbA1c concentrations noted that diabetic persons with HbA1c above 6.8% experienced a decrease in TBARS (biomarker of lipid peroxidation) whereas those with less than 6.0% experienced a mild increase, although total antioxidant capacity was increased only in the severely diabetic (above 8.5%) with no influence in the lower glycation groups.
Six months supplementation of 1,000mcg chromium to diabetic persons with varying HbA1c concentrations noted that diabetic persons with HbA1c above 6.8% experienced a decrease in TBARS (biomarker of lipid peroxidation) whereas those with less than 6.0% experienced a mild increase, although total antioxidant capacity was increased only in the severely diabetic (above 8.5%) with no influence in the lower glycation groups.
Antioxidant enzymes (glutathione peroxidase, SOD, catalase) were unchanged in all groups.
Antioxidant Effects Of Chromium Supplementation With Type 2 Diabetes Mellitus And Euglycemic Subjects
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ Months |
| 被験者数 | 64 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64 |
| 体型 | 肥満, 平均 |
この研究の注釈：
Six months supplementation of 1,000mcg chromium to diabetic persons with varying HbA1c concentrations noted that diabetic persons with HbA1c above 6.8% experienced a decrease in TBARS (biomarker of lipid peroxidation) whereas those with less than 6.0% experienced a mild increase, although total antioxidant capacity was increased only in the severely diabetic (above 8.5%) with no influence in the lower glycation groups.
Six months supplementation of 1,000mcg chromium to diabetic persons with varying HbA1c concentrations noted that diabetic persons with HbA1c above 6.8% experienced a decrease in TBARS (biomarker of lipid peroxidation) whereas those with less than 6.0% experienced a mild increase, although total antioxidant capacity was increased only in the severely diabetic (above 8.5%) with no influence in the lower glycation groups.
Antioxidant enzymes (glutathione peroxidase, SOD, catalase) were unchanged in all groups.
The Effects Of Chromium Supplementation On Endocrine Profiles, Biomarkers Of Inflammation, And Oxidative Stress In Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
| 効果 | 減少 |
| 数値 | Plasma total antioxidant capacity change over 8 weeks was 250.7 ± 265.2 chromium vs. +13.0 ± 201.6 mmol/L placebo, P < 0.001 |
| 試験方法 | ランダム化比較試験 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 60 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
この研究の注釈：
60 woman with PCOS were given either placebo or 200 µg chromium picolinate for 8 weeks. Chromium reduced acne, hirsutism, and C-reactive protein and improved plasma total antioxidant capacity but no change in reproductive hormones (FSH, LH, prolactin, and free testosterone).
